Bionano Genomics Inc (BNGO)

$1.15 0.00 (N/A)
Market Cap 11.70M
Revenue (ttm) 30.78M
Net Income (ttm) -112.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -363.94%
Debt to Equity Ratio 0.00
Volume 115,000
Avg Vol 206,842
Day's Range N/A - N/A
Shares Out 10.18M
Stochastic %K 70%
Beta 1.68
Analysts Strong Sell
Price Target $7.50

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 858 888 7600
Website: bionano.com
Address:
9540 Towne Centre Drive, Suite 100, San Diego, United States
MisterNessuno
MisterNessuno Feb. 27 at 4:36 PM
$BNGO Tic Toc Tic Toc ... (buy now)
0 · Reply
nikosgold
nikosgold Feb. 24 at 9:17 PM
$BNGO close this stuff...fcuk holmin
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 24 at 4:25 AM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
Muscle_Daddy
Muscle_Daddy Feb. 23 at 9:32 AM
$BNGO what's BNGO's Catalyst? Another revers split isn't a catalyst.. 🤣
0 · Reply
BigTimePennyStocks
BigTimePennyStocks Feb. 22 at 6:33 PM
Small-Caps with Catalysts this week: 👇👇 ( $ORKT, $COCH, $BNGO, $ERNA, etc...) #NASDAQ #NYSE
0 · Reply
NoEmotionzTrade
NoEmotionzTrade Feb. 19 at 4:04 AM
AGAE holding strength and tightening under resistance. .50 is the breakout trigger. Once that level clears with volume, .75 easily $ASRT $BNGO $LXRX $TYRA
1 · Reply
Pinto72
Pinto72 Feb. 17 at 8:56 PM
$ATOS This trash reminds me of $BNGO Congrats @Landsman 🤣🤣🤣🤣🤣
1 · Reply
pachi83
pachi83 Feb. 17 at 3:53 AM
$BNGO needs to stay above 1.45 for this to get ready to test 1.95/2.45, 3.4/4.28 and hopefully 5.75/7.96
2 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 16 at 2:20 PM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
TheWayISeeIt
TheWayISeeIt Feb. 13 at 7:32 PM
$BNGO One of my all-time best stocks. Sad what’s happened to it since…
1 · Reply
Latest News on BNGO
Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

Feb 27, 2026, 8:00 AM EST - 1 day ago

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

Feb 26, 2026, 8:00 AM EST - 2 days ago

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM's Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

Feb 25, 2026, 8:00 AM EST - 3 days ago

11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

Feb 24, 2026, 8:00 AM EST - 4 days ago

9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

Feb 9, 2026, 9:05 AM EST - 19 days ago

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

Feb 4, 2026, 8:00 AM EST - 24 days ago

Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Dec 3, 2025, 8:00 AM EST - 3 months ago

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 7:01 PM EST - 3 months ago

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Nov 13, 2025, 4:01 PM EST - 3 months ago

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Nov 6, 2025, 8:00 AM EST - 4 months ago

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

Oct 30, 2025, 4:05 PM EDT - 4 months ago

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

Bionano to Participate in the H.C. Wainwright @ Home Event

Oct 7, 2025, 8:00 AM EDT - 5 months ago

Bionano to Participate in the H.C. Wainwright @ Home Event

Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

Sep 18, 2025, 9:59 AM EDT - 5 months ago

Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Sep 17, 2025, 5:00 PM EDT - 5 months ago

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge

Sep 16, 2025, 1:41 PM EDT - 5 months ago

Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Sep 16, 2025, 7:00 AM EDT - 5 months ago

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Sep 15, 2025, 7:00 AM EDT - 5 months ago

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 8:00 AM EDT - 6 months ago

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript

Aug 15, 2025, 4:37 AM EDT - 7 months ago

Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Aug 14, 2025, 4:01 PM EDT - 7 months ago

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Aug 7, 2025, 8:00 AM EDT - 7 months ago

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 6, 2025, 8:00 AM EDT - 7 months ago

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

Jul 31, 2025, 4:05 PM EDT - 7 months ago

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 19, 2025, 8:00 AM EDT - 10 months ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript

May 14, 2025, 7:46 PM EDT - 10 months ago

Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 14, 2025, 4:01 PM EDT - 10 months ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 13, 2025, 8:00 AM EDT - 10 months ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 7, 2025, 4:01 PM EDT - 10 months ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

May 2, 2025, 9:30 AM EDT - 10 months ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 23, 2025, 8:00 AM EDT - 11 months ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Apr 8, 2025, 8:00 AM EDT - 11 months ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:11 PM EDT - 11 months ago

Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 31, 2025, 4:01 PM EDT - 11 months ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 24, 2025, 8:00 AM EDT - 1 year ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 18, 2025, 8:00 AM EDT - 1 year ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 14, 2025, 8:00 AM EDT - 1 year ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Mar 13, 2025, 9:00 AM EDT - 1 year ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Bionano Announces Effective Date of Reverse Stock Split

Jan 22, 2025, 4:05 PM EST - 1 year ago

Bionano Announces Effective Date of Reverse Stock Split

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 6, 2025, 4:30 PM EST - 1 year ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 31, 2024, 3:26 PM EST - 1 year ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Dec 23, 2024, 8:30 AM EST - 1 year ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 7:11 PM EST - 1 year ago

Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 13, 2024, 4:01 PM EST - 1 year ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Nov 4, 2024, 4:14 AM EST - 1 year ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 31, 2024, 8:10 AM EDT - 1 year ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)

Aug 13, 2024, 7:23 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)

Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 7:11 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript

MisterNessuno
MisterNessuno Feb. 27 at 4:36 PM
$BNGO Tic Toc Tic Toc ... (buy now)
0 · Reply
nikosgold
nikosgold Feb. 24 at 9:17 PM
$BNGO close this stuff...fcuk holmin
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 24 at 4:25 AM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
Muscle_Daddy
Muscle_Daddy Feb. 23 at 9:32 AM
$BNGO what's BNGO's Catalyst? Another revers split isn't a catalyst.. 🤣
0 · Reply
BigTimePennyStocks
BigTimePennyStocks Feb. 22 at 6:33 PM
Small-Caps with Catalysts this week: 👇👇 ( $ORKT, $COCH, $BNGO, $ERNA, etc...) #NASDAQ #NYSE
0 · Reply
NoEmotionzTrade
NoEmotionzTrade Feb. 19 at 4:04 AM
AGAE holding strength and tightening under resistance. .50 is the breakout trigger. Once that level clears with volume, .75 easily $ASRT $BNGO $LXRX $TYRA
1 · Reply
Pinto72
Pinto72 Feb. 17 at 8:56 PM
$ATOS This trash reminds me of $BNGO Congrats @Landsman 🤣🤣🤣🤣🤣
1 · Reply
pachi83
pachi83 Feb. 17 at 3:53 AM
$BNGO needs to stay above 1.45 for this to get ready to test 1.95/2.45, 3.4/4.28 and hopefully 5.75/7.96
2 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 16 at 2:20 PM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
TheWayISeeIt
TheWayISeeIt Feb. 13 at 7:32 PM
$BNGO One of my all-time best stocks. Sad what’s happened to it since…
1 · Reply
janed102
janed102 Feb. 13 at 12:21 PM
$BNGO anyone buying for the conference?? Surprised that this ticker only has 12% short float, thought it would be much higher.
0 · Reply
MisterNessuno
MisterNessuno Feb. 13 at 8:09 AM
$BNGO Ok guys, under 1,1 is a pick. Important SL (0,98) at last 15 min of the day trading.
0 · Reply
janed102
janed102 Feb. 12 at 7:53 PM
$BNGO anyone know how many times you can reverse spilt before delisting
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 12 at 8:37 AM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply
LeeSo
LeeSo Feb. 12 at 2:45 AM
$BNGO … Well, lunch is now out of the question… maybe I can afford a mid level breakfast at Denny’s with my shares! That’s 16 shares @4.5k a share unless they slipped in another reverse split!!! <chuckling> I’d say GL but most/ a lot of us know better… SMH
1 · Reply
BigMattAttack
BigMattAttack Feb. 11 at 5:05 AM
$BNGO certified garbage. Was a nice 10 bagger for me once upon a time but that Holman or whatever is name is a complete buffoon. Feel sorry for those that stuck around through the splits. Just delist and put it out of its misery.
1 · Reply
rcarigl23
rcarigl23 Feb. 9 at 9:21 PM
$BNGO
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 9 at 2:05 PM
$BNGO ​​BNGO Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
3 · Reply
HillbillyBullTrader
HillbillyBullTrader Feb. 7 at 11:21 AM
$BNGO Just to put things in the right perspective For the OG’s here remember the time at 2020 when the price skyrocket 3000% in a month? The company value now is 99.7% lower than the price was before this 3000% jump 🤣
1 · Reply
DNA2RNA2Protein
DNA2RNA2Protein Feb. 5 at 5:01 PM
$BNGO Fifteen years of Erik Holmlin running the show: reverse splits, dilution, broken promises, and wiped-out shareholders. The results speak for themselves.
0 · Reply
MickfromBullettown
MickfromBullettown Feb. 5 at 4:01 PM
$BNGO LoL This garbage company and stock never fails to tank on Holmlins white paper publication PR's. Never. One more "rave review" should get this to around $0.60 or so where it belongs. LMAO
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Feb. 5 at 4:25 AM
Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.
0 · Reply